Arver S, Sinha-Hikim I, Beall G, et al. Serum dihydrotestosterone and testosterone concentrations in human immunodeficiency virus-infected men with and without weight loss. J Androl. 1999;20(5):611–8.
Raffi F, Brisseau JM, Planchon B, et al. Endocrine function in HIV infected patients: a prospective study. AIDS. 1991;5:729–33.
Wunder DM, Bersinger NA, Fux CA, et al. Hypogonadism in HIV-1 infected men is common and does not resolve during antiretroviral therapy. Antivir Ther. 2007;12:261–5.
•• Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:2536–59. Review of clinical trial data for HIV and non-HIV infected men with androgen deficiency and expert recommendation for treatments
Dobs A. Role of testosterone in maintaining lean body mass and bone density in HIV-infected patients. Int J Impot Res. 2003;15(Suppl 4):S21–5.
Klein RS, Lo Y, Santoro N, et al. Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis. 2005;41:1794–803.
Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab. 1983;56:1278.
Purifoy FE, Koopmans LH, Mayes DM. Age differences in serum androgen levels in normal adult males. Hum Biol. 1981;53:499–501.
Ho CK, Stoddart M, Walton M, et al. Calculated free testosterone in men: comparison of four equations and with free androgen index. Ann Clin Biochem. 2006;43:389–97.
• Monroe AK, Dobs AS, Palella FJ, et al. Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism. AIDS Res Ther. 2014;11(1):6–9. Review of interpretation of biochemical testosterone assays among HIV infected men
Schwartz ID, Root AW. Klinefelter syndrome of testicular dysgenesis. Endocrinol Meta Clin North Am. 1991;20:153–8.
Patel P, Hanson DL, Sullivan PS, et al. Incidence of non-AIDS defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003;21:3447–53.
Yuan J. Genitourinary presentation of tuberculosis. Rev Urol. 2015;17:102–5.
Hartley RA. Mycobacterium avium infection presenting as a testicular mass in an immunocompromised patient. Cases J. 2009;2:8975.
Chu CY, Chen WY, Shauh-Der Y, et al. Syphilitic orchitis mimicking testicular tumour in clinically occult HIV infected men. Diagn Path. 2016;11:4.
Saccente M, Woods GL. Clinical and laboratory update on blastomycosis. Clin Micro Rev. 2010;23:367–81.
Philip J, Selvan D, Desmond AD. Mumps orchitis in the non-immune postpubertal male: threat to male fertility? BJU Int. 2006;97:138–41.
Merrill JE, Koyanagi Y, Chen IS. Interleukin-1 and tumour necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to CD4 receptor. J Virol. 1989;63:4404–8.
Baker HW, Burger HG, de Kretser DM, et al. Study of endocrine manifestations of hepatic cirrhosis. Q J Med. 1976;45:145–8.
Holdsworth S, Atkins RC, de Kretser DM. Pituitary-testicular axis in men with chronic renal failure. NEJM. 1977;296:1245–8.
Dobs AS, Dempsey MA, Ladenson PW, Polk F. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med. 1988;84(3 pt 2):611–6.
Wolfe Q, Hood B, Barker J, et al. Primary central nervous system lymphoma mimicking apoplexy: case report. Pituitary. 2009;12:76–9.
Spinner C, Noe S, Schwerdtfeger C, Todorova A, et al. Acute hypophysitis and hypopituitarism in syphilitic meningitis in HIV infected patient. BMC Infect Dis. 2013;13:481.
Husain N, Husain M, Rao P. Pituitary tuberculosis mimicking granulomatous hypophysitis. Pituitary. 2008;11:313–5.
Heary RF, Maniker AH, Wolansky LJ. Candidal pituitary abscess: case report. Neurosurgery. 1995;36:1009–12.
Sano T, Kovacs K, Scheithauer BW. Pituitary pathology in acquired immunodeficiency syndrome. Arch Path Lab Med. 1989;113:1066–70.
Rahnema CD, Lipshultz LI, Crosnoe LE, et al. Anabolic steroid induced hypogonadism: diagnosis and treatment. Fert Steril. 2014;101:1271–9.
Glass AR, Swerdloff RS, Bray GA, et al. Low serum testosterone and sex hormone binding globulin in obese men. J Clin Endocrinol Metab. 1977;45:1211–4.
Monroe AK, Dobs AS, Xu X, et al. Sex hormones, insulin resistance and diabetes mellitus among with or at risk for HIV infection. J Acquir Immune Defic Syndr. 2011;58:173–80.
Dube MP, Parker RA, Mulligan K, et al. Effects of potent antiretroviral treatment on free testosterone levels and fat free mass in men in a prospective randomised trial: A5005s, a substudy of AIDS Clinical Trials Study 384. Clin Infect Dis. 2007;45:120–6.
Reitschel P, Corcoran C, Stanley T, et al. Prevalence of hypogonadism among men with weight loss related to HIV infection who were receiving highly active antiretroviral therapy. Clin Infect Dis. 2000;11:1120–244.
Crum-Cianflone NF, Bavaro M, Hale B, et al. Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care ST. 2007;21:9–19.
Rochira V, Diazzi C, Santi D, et al. Low testosterone is associated with poor health status in men with HIV infection: retrospective study. Andrology. 2015;3:298–308.
Sikora MJ, Rae JM, Johnson MD, et al. Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growth. HIV Medicine. 2010;11:603–60735.
Bedimo R, Maalouf NM, Zhang S, et al. Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. AIDS. 2012;26:825–31.
Asboe D, Aitken C, Boffito M, et al. British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals. HIV Medicine. 2011;13:1–44.
• Kong A, Edmonds P. Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis. Lancet Infect Dis. 2002;2:692–9. Review and meta-analysis of clinical trials to evaluate testosterone replacement in HIV infected men
Grinspoon S, Corcoran C, Askari H, et al. Effects of androgen administration in men with the AIDS wasting syndrome: a randomised, double-blind, placebo-controlled trial. Ann Intern Med. 1998;128:18–26.
Bhasin S, Storer TW, Asbel-Sethi N, et al. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab. 1998;83:3155–62.
Knapp PE, Storer TW, Herbst KL, et al. Effects of supraphysiological dose of testosterone on physical function, muscle performance, mood and fatigue in HIV associated weight loss. Am J Phys. 2008;294:1135–43.
Bhasin S, Storer TW, Javanbakht M, et al. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA. 2000;283:763–70.
Grinspoon S, Corcoran C, Stanley T, et al. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. J Clin Endocr Metab. 2000;85:60–5.